Report - Dossier zur Nutzenbewertung gemäß § 35a SGB V · PTPN3 Protein tyrosine phosphatase non-receptor type 3 PZN Pharmazentralnummer Raf rapidly accelerated fibrosarcoma RAS Proto-Onkogen

Please pass captcha verification before submit form